MedTrace Logo

Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients

NCT02518971 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 176

Last updated 2019-04-12

Study results available
· View outcomes & findings →

Summary

The study aims to evaluate the efficacy of prophylactic tamsulosin in reducing the incidence of postoperative urinary retention in primary total knee and hip arthroplasty patients.

Conditions

  • Postoperative Urinary Retention

Interventions

DRUG

Tamsulosin

0.4 mg daily

DRUG

Placebo

one capsule daily

Sponsors & Collaborators

Principal Investigators

  • Andrew Urquhart, MD · University of Michigan, Dept of Orthopaedic Surgery

  • Manuel Schubert, MD · University of Michigan, Dept of Orthopaedic Surgery

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2018-06-05
Completion
2018-12-19
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02518971 on ClinicalTrials.gov